Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

NRF2 CYSTEINE RESIDUES ARE CRITICAL FOR OXIDANT/ELECTROPHILE-SENSING, KEAP1-DEPENDENT UBIQUITINATION-PROTEASOMAL DEGRADATION, AND TRANSCRIPTION ACTIVATION

Xiaoqing He and Qiang Ma
Molecular Pharmacology September 28, 2009, mol.109.058453; DOI: https://doi.org/10.1124/mol.109.058453
Xiaoqing He
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qiang Ma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Cells respond to oxidants and electrophiles by activating receptor/transcription factor Nrf2 to coordinate induction of cytoprotective genes critical for defense against oxidative and other stresses. Activation involves blocking the ubiquitination-proteasomal degradation of Nrf2. Modification of cysteine thiol groups by inducers in the linker region of Keap1, which congregates Nrf2 into the Keap1/Cul3 E3 complex for ubiquitination, is important but not sufficient for activation of Nrf2. Here we show that evolutionally conserved cysteine residues of Nrf2 are critical for Nrf2 regulation. FlAsH (an arsenic-based fluorophore) and phenylarsine oxide (PAO) potently induce Nrf2 target genes and bind to Nrf2 in vitro and in vivo. Binding is inhibited by prototypical inducers arsenic and tBHQ. PAO affinity pulldown and mutation of individual cysteine to alanine reveal that C235, C311, C316, C414, and C506 are critical for binding and binding is modulated by intra-molecular interactions. To corroborate the functions of cysteine residues, Nrf2 wild-type or mutants are expressed in Nrf2 knockout cells to reconstitute Nrf2 regulation. Nrf2 mutants have reduced t1/2 that inversely correlates with increased binding to Keap1 and polyubiquitination of mutant proteins. Remarkably, the mutants fail to respond to arsenic for Nrf2 activation and gene induction. Furthermore, mutations at C119, C235, and C506 impede binding of Nrf2 to endogenous ARE and to coactivator CBP/p300. The findings demonstrate that Nrf2 cysteine residues critically regulate oxidant/electrophile sensing, repress Keap1-dependent ubiquitination-proteasomal degradation, and promote recruitment of co-activators, such that chemical sensing, receptor activation, and transcription activation are integrated at the receptor molecule.

  • Regulation of gene expression
  • Phase II enzymes
  • Regulation - transcriptional
  • Regulation - xenobiotic
  • Oxidative stress/antioxidants
  • Toxicant-induced gene express

Footnotes

    • Received June 8, 2009.
    • Revision received September 21, 2009.
    • Accepted September 28, 2009.
  • The American Society for Pharmacology and Experimental Therapeutics
Next
Back to top

In this issue

Molecular Pharmacology: 99 (5)
Molecular Pharmacology
Vol. 99, Issue 5
1 May 2021
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
NRF2 CYSTEINE RESIDUES ARE CRITICAL FOR OXIDANT/ELECTROPHILE-SENSING, KEAP1-DEPENDENT UBIQUITINATION-PROTEASOMAL DEGRADATION, AND TRANSCRIPTION ACTIVATION
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

NRF2 CYSTEINE RESIDUES ARE CRITICAL FOR OXIDANT/ELECTROPHILE-SENSING, KEAP1-DEPENDENT UBIQUITINATION-PROTEASOMAL DEGRADATION, AND TRANSCRIPTION ACTIVATION

Xiaoqing He and Qiang Ma
Molecular Pharmacology September 28, 2009, mol.109.058453; DOI: https://doi.org/10.1124/mol.109.058453

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

NRF2 CYSTEINE RESIDUES ARE CRITICAL FOR OXIDANT/ELECTROPHILE-SENSING, KEAP1-DEPENDENT UBIQUITINATION-PROTEASOMAL DEGRADATION, AND TRANSCRIPTION ACTIVATION

Xiaoqing He and Qiang Ma
Molecular Pharmacology September 28, 2009, mol.109.058453; DOI: https://doi.org/10.1124/mol.109.058453
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • 6-Methylflavone Blocks Bitterness of Tenofovir
  • Positive Allosteric Modulation of the mGlu5 Receptor
  • Correction of mutant CNGA3 channel trafficking defect
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics